Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy
Clinical and Translational Medicine · 2023
DOI: 10.1002/ctm2.1258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Xiaolei Cheng und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China …. Hauptthemen laut MEDLINE: MicroRNAs, Cardiomyopathy, Dilated, Heart Failure. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Cardiac‐resident or ‐enriched microRNAs (miRNAs) could be released into the bloodstream becoming circulating cardiac miRNAs, which are increasingly recognized as non‐invasive and accessible biomarkers of multiple heart diseases. However, dilated cardiomyopathy (DCM)‐associated circulating miRNAs (DACMs) and their roles in DCM pathogenesis remain largely unexplored.
Methods
Two human cohorts, consisting of healthy individuals and DCM patients, were enrolled for serum miRNA sequencing (10 vs. 10) and quantitative polymerase chain reaction validation (46 vs. 54), respectively. Rigorous screening strategy was enacted to define DACMs and their potentials for diagnosis. DCM mouse model, different sources of cardiomyocytes, adeno‐associated virus 9 (AAV9), gene knockout, RNAscope miRNA in situ hybridization, mRFP‐GFP‐LC3B reporter, echocardiography and transmission electron microscopy were adopted for mechanistic explorations.
Results
Serum miRNA sequencing revealed a unique expression pattern for DCM circulating miRNAs. DACMs miR‐26a‐5p, miR‐30c‐5p, miR‐126‐5p and miR‐126‐3p were found to be depleted in DCM circulation as well as heart tissues. Their expressions in circulation and heart tissues were proven to be correlated significantly, and a combination of these miRNAs was suggested potential values for DCM diagnosis. FOXO3, a predicted common target, was experimentally demonstrated to be co‐repressed within cardiomyocytes by these DACMs except miR‐26a‐5p. Delivery of a combination of miR‐30c‐5p, miR‐126‐5p and miR‐126‐3p into the murine myocardium via AAV9 carrying an expression cassette driven by cTnT promoter, or cardiac‐specific knockout of FOXO3 (Myh6‐Cre ERT2 , FOXO3 flox +/+ ) dramatically attenuated cardiac apoptosis and autophagy involved in DCM progression. Moreover, competitively disrupting the interplay between DACMs and FOXO3 mRNA by specifically introducing their interacting regions into murine myocardium crippled the cardioprotection of DACMs against DCM.
Conclusions
Circulating cardiac miRNA‐FOXO3 axis plays a pivotal role in safeguarding against myocardial apoptosis and excessive autophagy in DCM development, which may provide serological cues for DCM non‐invasive diagnosis and shed light on DCM pathogenesis and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital of Zhengzhou University, Fuwai Central China Cardiovasc…
- Department of Anesthesiology, Affiliated Drum Tower Hospital of Medical School of Nanjing University, Nanjing, China.
- Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing,…
- Henan Key Laboratory of Chronic Disease Management, Department of Health Management Center, Henan Provincial People's Hospital, Department of Health Management Center of Central China Fuwai Hospital, Central China Fuwai…
- Department of Physiology, Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Hao Tang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cheng, X., Jian, D., Xing, J., Liu, C., Liu, Y., Cui, C., Li, Z., Wang, S., Li, R., Ma, X., Wang, Y., Gu, X., Ge, Z., Tang, H., & Liu, L. (2023). Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1258
Vancouver
Cheng X, Jian D, Xing J, Liu C, Liu Y, Cui C, et al. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1258
BibTeX
@article{Cheng2023,
author = {Cheng, Xiaolei and Jian, Dongdong and Xing, Junyue and Liu, Cihang and Liu, Yong and Cui, Cunying and Li, Zhen and Wang, Shixing and Li, Ran and Ma, Xiaohan and Wang, Yingying and Gu, Xiaoping and Ge, Zhenwei and Tang, Hao and Liu, Lin},
title = {Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy},
journal = {Clinical and Translational Medicine},
year = {2023},
doi = {10.1002/ctm2.1258}
}
EUVIMED